Ownership history in US BANCORP \DE\ · 29 quarters on record
This page tracks every 13F SEC filing in which US BANCORP \DE\ reported a position in VERONA PHARMA PLC A D R (VRNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 6,762 | -1,146 | -14.5% | 0.00% | $722K | — |
| 2025 Q2 | REDUCED | 7,908 | -701 | -8.1% | 0.00% | $748K | — |
| 2025 Q1 | REDUCED | 8,609 | -18 | -0.2% | 0.00% | $547K | — |
| 2024 Q4 | REDUCED | 8,627 | -13,328 | -60.7% | 0.00% | $401K | — |
| 2024 Q3 | REDUCED | 21,955 | -1,980 | -8.3% | 0.00% | $632K | — |
| 2024 Q2 | ADDED | 23,935 | +113 | +0.5% | 0.00% | $346K | — |
| 2024 Q1 | REDUCED | 23,822 | -18,280 | -43.4% | 0.00% | $383K | — |
| 2023 Q4 | REDUCED | 42,102 | -12,826 | -23.4% | 0.00% | $837K | — |
| 2023 Q3 | REDUCED | 54,928 | -7,897 | -12.6% | 0.00% | $895K | — |
| 2023 Q2 | REDUCED | 62,825 | -7,076 | -10.1% | 0.00% | $1.3M | — |
As of 2025 Q3 — sorted by position size